Involvement of four different intracellular sites in chloroacetaldehyde- induced oxidative stress cytotoxicity

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 1, 2012, Pages 265-276

  Pourahmad, Jalal ^a   Hosseini, Mir Jamal ^a,b   Eskandari, Mohammad Reza ^a   Rahmani, Faezeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chloroacetaldehyde; Hepatocyte; Mitochondrial lysosomes cross talk; Oxidative stress; Xanthine oxidase

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ANTIOXIDANT; CARNITINE; CHLOROACETALDEHYDE; CHLOROQUINE; CYTOCHROME P450; DIMETHYL SULFOXIDE; FRUCTOSE; GLUTAMINE; GLUTATHIONE; MANNITOL; METHYLAMINE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; OXIPURINOL; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; LIVER CELL; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 84858613242     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Green RM, Hodges NJ, Chipman JK, O'Donovan MR and Graham M. Reactive oxygen species from the uncoupling of human cytochrome P450 1B1 may contribute to the carcinogenicity of dioxin-like polychlorinated biphenyls. Mutagenesis (2008) 23: 457-63.
2. Alaluusua S and Lukinmaa PL. Developmental dental toxicity of dioxin and related compounds-a review. Int. Dent. J. (2006) 56: 323-31.
3. Bartsch H and Montesano R. Mutagenic and carcinogenic effects of vinyl chloride. Mutat. Res. (1975) 32: 93-114.
4. Giraud B, Hebert G, Deroussent A, Veal GJ, Vassal G and Paci A. Oxazaphosphorines: new therapeutic strategies for an old class of drugs. Expert. Opin. Drug Metab. Toxicol. (2010) 6: 919-38.
5. Singer B. DNA damage: chemistry, repair, and mutagenic potential. Regul. Toxicol. Pharmacol. (1996) 23: 2-13.
6. Guengerichg FP, Crawford WM and Watanabe PG. Activation of vinyl chloride to covalently bound metabolites: Roles of 2-chloroethylene oxide and 2-chloroacetaldehyde. Biochemistry (1979) 18: 5177-82.
7. Guengerich FP, Crawford WM, Domoradzki J, MacDonald TL and Watanabe PG. In-vitro activation of 1, 2-dichloroethane by microsomal and cytosolic enzymes. Toxicol. Appl. Pharmacol. (1980) 55: 303-17.
8. Purchase IF, Stafford J and Paddle GM. Vinyl chloride: an assessment of the risk of occupational exposure. Food Chem. Toxicol. (1987) 25: 187-202.
9. Kandala JC, Mrema JE, DeAngelo A, Daniel FB and Guntaka RV. 2-Chloroacetaldehyde and 2-chloroacetal are potent inhibitors of DNA synthesis in animal cells. Biochem. Biophys. Res. Commun. (1990) 167: 457-63.
10. Daniel FB, DeAngelo AB, Stober JA, Olson GR and Page NP. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. (1992) 19: 159-68.
11. Sood C and O'Brien PJ. Molecular mechanisms of chloroacetaldehyde-induced cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol. (1993) 46: 1621-6.
12. Sharpe AL and Carter DE. Substrate specificity of rat liver aldehyde dehydrogenase with chloroacetaldehydes. J. Biochem. Toxicol. (1993) 8: 155-60.
13. Yaseen Z, Michoudet C, Baverel G and Dubourg L. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule. Arch. Toxicol. (2008) 82: 607-14.
14. Knouzy B, Dubourg L, Baverel G and Michoudet C. Targets of chloroacetaldehyde-induced nephrotoxicity. Toxicol. In-vitro (2010) 24: 99-107.
15. Visarius TM, Stucki JW and Lauterburg BH. Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J. Pharmacol. Exp. Ther. (1999) 289: 820-4.
16. Moldeus P, Hogberg J and Orrenius S. Isolation and use of liver cells. Meth. Enzymol. (1978) 52: 60-71.
17. Pourahmad J, Eskandari MR and Daraei B. A comparison of hepatocyte cytotoxic mechanisms for thallium (I) and thallium (III). Environ. Toxicol. (2010) 25: 456-67.
18. Khan S and O'Brien PJ. 1-Bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem. Biophys. Res. Commun. (1991) 179: 436-41.
19. Galati G, Teng S, Moridani MY, Chan TS and O'Brien PJ. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol. Drug Interact. (2000) 17: 311-49.
20. Pourahmad J, Hosseini M-J, Bakan S and Ghazi-Khansari M. Hepatoprotective activity of angiotensin-converting enzyme (ACE) inhibitors, captopril and enalapril, against paraquat toxicity. Pestic. Biochem. Physiol. (2011) 99: 105-10.
21. Pourahmad J, Eskandari MR, Nosrati M, Kobarfard F and Khajeamiri AR. Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition. Eur. J. Pharmacol. (2010) 643: 162-9.
22. Pourahmad J, Rezaei M, Rezvani N, Ahmadiani A. Impact of Duration and Severity of Persistent Pain on Programmed Cell Death. Iranian J. Pharm. Res. (2006) 5 (3): 203-8.
23. Andersson BS, Aw TY and Jones DP. Mitochondrial transmembrane potential and pH gradient during anoxia. Am. J. Physiol. (1987) 252: 349-55.
24. Brüggemann SK, Radike K, Braasch K, Hinrichs J, Kisro J, Hagenah W, Peters SO and Wagner T. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite. Cancer Chemother. Pharmacol. (2006) 57: 349-56.
25. Li F, Patterson AD, Höfer CC, Krausz KW, Gonzalez FJ and Idle JR. Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochem. Pharmacol. (2010) 80: 1063-74.
26. Benesic A, Schwerd G, Mildenberger S, Freudinger R, Gordjani N and Gekle M. Disturbed Ca2+-signaling by chloroacetaldehyde: A possible cause for chronic ifosfamide nephrotoxicity. Kidney Int. (2005) 68: 2029-41.
27. Nissim I, Horyn O, Daikhin Y, Nissim I, Luhov B, Phillips PC and Yudkoff M. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res. (2006) 66: 7824-31.
28. Springate JE. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in-vivo. J. Appl. Toxicol. (1997) 17: 75-9.
29. Pourahmad J, Mortada Y, Eskandari MR, Shahraki J. Involvement of lysosomal labilisation and lysosomal/mitochondrial cross-talk in diclofenac induced hepatotoxicity. Iranian J. Pharm. Res. (2011) 10: 877-887.
30. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox. Signal (2005) 7: 1140-9.
31. Kellogg EW, Fridovich I Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J. Biol. Chem. (1975) 250: 8812-7.
32. Shaw S and Jayatilleke E. Acetaldehyde-mediated hepatic lipid peroxidation: role of superoxide and ferritin. Biochem. Biophys. Res. Commun. (1987) 143: 984-90.
33. O'Brien PJ, Kaul H, McGirr L and Silva J. Molecular mechanisms for the involvement of the aldehydic metabolites of lioid oeroxides in cvtotoxicitv and carcinogenesis. In: Kabara JJ. (ed.) Pharmacological Effects of Lipids III. The American Oil Chemists Society, Champaign (1988) 266-280.
34. Boelsterli U. Xenobiotic-induced oxidative stress: cell injury, signaling, and gene regulation. In: (ed.) Mechanistic Toxicology: The Molecular Basis of How Chemicals Disrupt Biological Targets. CRC Press, Boca Raton (2007) 117-75.
35. Boveris A, Fraga CG, Varsavsky AI and Koch OR. Increased chemiluminescence and superoxide production in the liver of chronically ethanol-treated rats. Arch. Biochem. Biophys. (1983) 227: 534-41.
36. Ekstrom G and Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem. Pharmacol. (1989) 38: 1313-9.
37. Rashba-Step J, Turro NJ and Cederbaum AI. Increased NADPH and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch. Biochem. Biophys. (1993) 300: 401-8.
38. Grimm S and Brdiczka D. The permeability transition pores in cell death. Apoptosis (2007) 12: 841-55.
39. 2+. Toxicology (2000) 143: 263-73.
40. Pourahmad J, Hosseini MJ, Eskandari MR, Shekarabi SM and Daraei B. Mitochondrial / lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity. Xenobiotica (2010) 40: 763-71.